These findings collectively point to an under-recognized pathophysiological process wherein spaying-induced hypergonadotropinemia may drive malignant progression through LHR/FSHR-mediated, non-sex-hormone-dependent pathways that reshape the tumor microenvironment. The gene discussed is LHCGR; the disease is neoplasm.